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Activation of the IkBa Kinase Complex
by MEKK1, a Kinase of the JNK Pathway
Frank S. Lee,* Jeremiah Hagler,* Zhijian J. Chen,² kinases that they directly activate, such as PAK (Bag-
rodia et al., 1995). MEKK1 (Lange-Carter et al., 1993) isand Tom Maniatis*
*Department of Molecular and Cellular Biology then activated by these proteins by a mechanism yet to
be determined. MEKK1 then activates MKK4, which inHarvard University
7 Divinity Avenue turn activates JNK (Sanchez et al., 1994; Yan et al., 1994;
Derijard et al., 1995). Among the substrates of JNK areCambridge, Massachusetts 02138
²ProScript, Inc. c-Jun, ATF-2, and Elk-1 (Derijard et al., 1994; Kyriakis
et al., 1994; Gupta et al., 1995; Whitmarsh et al., 1995).38 Sidney Street
Cambridge, Massachusetts 02139 While the signal transduction cascade leading to the
activation of JNK is relatively well defined, the steps
leading to the phosphorylation of IkBa are poorly under-
stood. Many of the stimuli that induce NF-kB, such asSummary
TNF-a, UV irradiation, and lipopolysaccharide, also acti-
vate the JNK cascade, thereby raising the possibility thatBoth NF-kB and c-Jun are activated by cytokines such
the two pathways utilize common signal transductionas TNF-a and by stresses such as UV irradiation. A
components. Indeed, transfection of MEKK1 induceskey step in the activation of NF-kB is the phosphoryla-
the degradation of IkBa and activates an NF-kB reportertion of its inhibitor, IkBa, by a ubiquitination-inducible
gene (Hirano et al., 1996; Meyer et al., 1996), suggestingmultiprotein kinase complex (IkBa kinase). A central
a link between the NF-kB and JNK pathways. Thesekinase in the c-Jun activation pathway is mito-
observations raise two critical questions. First, isgen-activated protein kinase/ERK kinase kinase-1
MEKK1-induced degradation mediated by the same(MEKK1). Here, we show that MEKK1 induces the site-
site-specific phosphorylation of IkBa identified in otherspecific phosphorylation of IkBa in vivo and, most
contexts? Second, and more importantly, what is thestrikingly, can directly activate the IkBa kinase com-
target of MEKK1 in the NF-kB pathway? Here, we showplex in vitro. Thus, MEKK1 is a critical component
that MEKK1 does in fact induce phosphorylation of IkBaof both the c-Jun and NF-kB stress response path-
at its sites of regulatory phosphorylation and that thisways. Since the IkBa kinase complex can be indepen-
occurs by direct activation of the IkBa kinase. Thus,dently activated by ubiquitination or MEKK1-dependent
MEKK1 is a critical coordinate regulator of both the NF-phosphorylation, it may be an integrator of multiple
kB and JNK pathways.signal transduction pathways leading to the activation
of NF-kB.
Results
Introduction
IkBa Kinase Activity Is Inducible by TNF-a
Previous studies left open the question of whether theExposure of cells to certain cytokines or environmental
stresses leads to the activation of the transcription fac- IkBa kinase is regulated by inducers of NF-kB. In those
studies, the IkBa kinase was detected as an apparentlytors NF-kB and c-Jun. In unstimulated cells, NF-kB is
sequestered in the cytoplasm in a complex with IkBa constitutive activity in S100 cytoplasmic extracts pre-
pared from uninduced HeLa cells using the hypotonicor another member of the IkB family of inhibitor proteins
(reviewed by Baldwin, 1996). Following stimulation by a lysis procedure of Dignam et al., 1983 (Chen et al., 1996).
Using an alternative method for preparing cytoplasmicvariety of inducers, NF-kB isactivated as a consequence
of the phosphorylation and subsequent proteolytic deg- extracts (a rapid lysis procedure detailed in Experimen-
tal Procedures), we now find that the IkBa kinase activityradation of the IkB protein. IkBa is phosphorylated at
Serine residues 32 and 36 (Brockman et al., 1995; Brown is inducible by TNF-a. HeLa cells were treated with
TNF-a for differing lengths of time, and the rapid lysiset al., 1995; Traenckner et al., 1995), an event that targets
this protein for degradation by the ubiquitin-proteasome extracts assayed for the presence of endogenous IkBa
by Western blotting and for IkBa kinase activity by incu-pathway (Chen et al., 1995; reviewed by Baldwin, 1996).
Recent studies have identified a large, multisubunit bation with exogenous 35S-labeled IkBa in the presence
of okadaic acid (Figures 1A and 1B). We note that incomplex in HeLa cell cytoplasmic extracts that can
phosphorylate IkBa at Ser-32 and -36 (the IkBa kinase, these and all subsequent experiments okadaic acid is
employed strictly as a phosphatase inhibitor (i.e., toChen et al., 1996). A novel property of this kinase, which
was isolated from unstimulated cells, is that it can be preserve the phosphorylated IkBa species) rather than
as an inducer of IkBa phosphorylation (Thevenin et al.,activated in vitro by ubiquitination.
A second branch of the stress response is the c-Jun 1990; Traenckner et al., 1995). Consistent with previous
results (Henkel et al., 1993; Mellits et al., 1993), extractsN-terminal kinase (JNK) pathway (also known as the
stress-activated protein kinase pathway; for recent re- from uninduced HeLa cells contain hypophosphorylated
IkBa (Figure 1A, lane 1), but after only 5 min of TNF-aviews and references see Karin, 1995, and Kyriakis and
Avruch, 1996). The JNK cascade can be activated by treatment a significant portion of the endogenous IkBa
is phosphorylated (as revealed by the slower migratingsmall GTP-binding proteins that include Cdc42 and
Rac1 (Coso et al., 1995; Minden et al., 1995), and protein IkBa species, lane 2). After 30 min of treatment, virtually
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Figure 1. IkBa Kinase Activity Is Inducible and Is Correlated With JNK Activity
(A) HeLa cells were treated with TNF-a for the indicated times, and cytoplasmic extracts prepared by the rapid lysis procedure. Extracts (14
mg) were then subjected to 10% SDS-PAGE, transferred to nitrocellulose membrane, and probed with anti-IkBa antibodies. The positions of
unphosphorylated (IkBa) and phosphorylated (P-IkBa) IkBa are indicated to the left. Molecular weight marker (in kilodaltons) is indicated to
the right.
(B) HeLa cells were treated with TNF-a for the indicated times, and cytoplasmic extracts prepared by the rapid lysis procedure. Extracts (9
mg) were then incubated with 35S-labeled IkBa in the absence or presence of 6 mM okadaic acid for 1 hr at 308C. Reaction products were
subjected to 9% SDS-PAGE and analyzed by autoradiography. The positions of unphosphorylated (IkBa) and phosphorylated (P-IkBa) IkBa
are indicated to the left.
(C) HeLa cells were either mock or TNF-a (5 min) treated, and cytoplasmic extracts prepared by the rapid lysis procedure. Extracts (8 mg)
were then incubated with 35S-labeled wild-type (WT) or mutant (S32A/S36A, M) IkBa, or wild-type (WT) or mutant (S63A/S73A, M) c-Jun for 0
or 60 min at 308C in the presence of 2.5 mM okadaic acid. Reaction products were subjected to 10% SDS-PAGE and analyzed by autoradiogra-
phy. Molecular weight markers (in kilodaltons) are indicated to the left. The positions of unphosphorylated (cJun) and phosphorylated (P-cJun)
c-Jun are indicated to the right; those for IkBa are indicated to the left.
(D) HeLa cell S100 extracts (18 mg) were incubated with 35S-labeled wild-type (WT) or mutant (S32A/S36A, M) IkBa, or wild-type (WT) or mutant
(S63A/S73A, M) c-Jun for 0 or 60 min at 308C in the presence of 2.5 mM okadaic acid. Reaction products were subjected to 10% SDS-PAGE
and analyzed by autoradiography. Molecular weight markers (in kilodaltons) are indicated to the left.
all of the IkBa is degraded (lane 3). Parallel assays with solely by inactivation of an okadaic acid±sensitive IkBa
phosphatase, implying that TNF-a treatment inducesthe same extracts reveal that the IkBa kinase activity is
absent in uninduced cells (Figure 1B, lane 2) (activity is IkBa kinase activity. Furthermore, the rapid induction of
IkBa kinase activity correlates with the rapid appear-weakly detectable when higher concentrations of these
extracts are employed). However, after exposure of cells ance of the phosphorylated form of IkBa.
to TNF-a for only 5 min, IkBa kinase activity can be
readily detected, as evidenced by the slower-migrating Coordinate Activation of IkBa Kinase
and JNK Activities In VitroIkBa species (lane 4). Fractionation of these extracts
by gel filtration reveals that the TNF-a-inducible IkBa TNF-a treatment also leads to the activation of c-Jun
by JNK (Hibi et al.,1993). We therefore carried out exper-kinase activity resides in a large (approximately 700 kDa)
complex (data not shown). Interestingly, this activity per- iments to determine whether the IkBa kinase and JNK
are coactivated in extracts from TNF-a-treated cells.sists and is present after 30 min of TNF-a induction
(lane 6), a time at which the endogenous IkBa has been Cytoplasmic extracts from uninduced and TNF-a-
induced HeLa cells were incubated with in vitro trans-degraded (Figure 1A, lane 3). IkBa kinase activity is es-
sentially absent at 60min (Figure 1B, lane 8). It is formally lated, 35S-labeled IkBa or c-Jun, and the proteins frac-
tionated by SDS-PAGE (Figure 1C). As before, IkBapossible that the IkBa kinase activity is constitutive and
that TNF-a treatment simply results in the inactivation kinase activity is detected in extracts from TNF-a-
induced cells but not in those from uninduced cellsof a phosphatase in the extract that dephosphorylates
IkBa. To address this possibility, the same extracts were (compare lanes 2 and 4). The specificity of phosphoryla-
tion is indicated by the fact that theS32A/S36A mutationincubated with 35S-labeled IkBa in the absence of oka-
daic acid (Figure 1B, lanes 1, 3, 5, and 7). Under these in IkBa completely abolishes the IkBa shift (lane 6).
Similarly, extracts from TNF-a-induced cells show JNKconditions, the IkBa mobility shift is completely abol-
ished (for example, compare lanes 3 and 4). Thus, the activity, as evidenced by the appearance of a c-Jun
species with markedly reduced mobility (compare laneseffects of TNF-a treatment cannot be accounted for
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9 and 10). The observed shift is a result of JNK activity, discussion, see Xu et al., 1996). Both kinases are consti-
tutively active and indistinguishable in transfection stud-since amino acid substitutions at the sites of JNK phos-
phorylation (S63A/S73A) in c-Jun abolish this shift (lane ies. As expected, MEKK1 activates the reporter linked
to a multimer of PRDIV (Figure 2A), which binds to either12). We note that a distinct shift is observed with the
c-Jun mutant, suggesting that JNK may phosphorylate an ATF-2 homodimer or an ATF-2/c-Jun heterodimer
(Du et al., 1993).Both ATF-2 and c-Jun contain transcrip-c-Jun at residues other than Ser-63and -73. Importantly,
extracts from uninduced cells show no significant JNK tional activation domains that are phosphorylated by
the JNK pathway (Gupta et al., 1995). Importantly,activity (lane 8). Thus, both the IkBa kinase and JNK
activities are activated in the rapid lysis extracts pre- MEKK1 also activates the PRDII reporter. MEKK1 does
not activate all promoters, since its effect on a reporterpared from TNF-a-treated, but not untreated, cells.
By contrast, the IkBa kinase activity is readily de- gene containing the intact IFN-b enhancer is only mar-
ginal. This enhancer contains additional PRDs that bindtected in S100 cytoplasmic extracts prepared from un-
stimulated HeLa cells using the hypotonic lysis proce- factors other than NF-kB or ATF-2/c-Jun (see Thanos et
al., 1993). As expected, the IFN-b enhancer is effectivelydure (Chen et al., 1995). It is possible that stress
pathways are activated by this procedure, since another activated by virus infection, which activates all of the
PRDs. We conclude that MEKK1 can activate both ATF-form of osmotic stress, hyperosmolar shock, has been
shown to be an efficient activator of the JNK pathway 2/c-Jun and NF-kB in vivo.
To examine whether MEKK1 plays a role in the activa-(Galcheva-Gargova et al., 1994). Indeed, both the IkBa
kinase and the JNK activities were detected when the tion of NF-kB in response to TNF-a, HeLa cells were
transfected with a PRDII reporter and expression vectorS100 extracts were incubated for 60 min (Figure 1D). A
time-dependent activation of JNK was detected when for catalytically inactive (K432M) MEKK1D, or empty ex-
pression vector. Some cells were then stimulated withthe S100 extracts were incubated and then examined
by an in-gel kinase assay employing the JNK substrate TNF-a, and subsequently all cells were harvested and
examined for reporter gene activity. As expected, TNF-aATF-2 (data not shown). Thus, both the JNK and IkBa
kinase may be activated during incubation of the S100 activates the PRDII reporter efficiently (Figure 2B). By
contrast, the mutant MEKK1D (K432M) inhibits both theextracts, possibly owing to the hypotonic lysis condi-
tions. basal and TNF-a-induced activity of this reporter, thus
behaving as a dominant negative inhibitor, as has also
been shown by Hirano et al. (1996). Similar results are
MEKK1 Activates NF-kB In Vivo observed in L929 cells (Figure 2C). As a negative control,
Transient transfection studies were conducted to exam- cAMP activation of a cAMP response element reporter is
ine the relationship between the activation of the IkBa not significantly affected by dominant negative MEKK1D
kinase and JNK in vivo. The IFN-b enhancer contains (Figure 2D). These results suggest that MEKK1 plays a
multiple positive regulatory domains (PRDs) that bind role in TNF-a activation of NF-kB.
distinct transcription factors, including NF-kB (PRDII)
and ATF-2/c-Jun (PRDIV) (reviewed in Thanos et al.,
1993). HeLa cells were transfected with reporters linked MEKK1 Activation of NF-kB Occurs through
Site-Specific Phosphorylation of IkBato either two copies of PRDII (PII), six copies of PRDIV
(PIV), or the intact IFN-b enhancer (IFN), which includes Numerous stimuli that activate NF-kB have been shown
to induce site-specific phosphorylation of IkBa at Ser-these as well as other PRDs, and either an expression
vector for MEKK1 or an expression vector alone. Note 32 and -36 (Brockman et al., 1995; Brown et al., 1995;
Traenckner et al., 1995). Experiments were thereforethat in these and all subsequent experiments, MEKK1
and MEKK1D refer to the 672 and 321 residue C-terminal conducted to examine whether MEKK1 induces this
same phosphorylation. HeLa cells were transfected withfragments, respectively, of the full-length molecule (for
Figure 2. MEKK1 Activates NF-kB In Vivo
(A) HeLa cells were transfected with 3 mg of
(PRDII)2CAT, (PRDIV)6CAT or -110IFN-bCAT,
2 mg pCMV-lacZ, and 4 mg of pCMV5-MEKK1
or pcDNA3. Twenty-six to 28 hr posttransfec-
tion, cells in one well were infected with Sen-
dai virus for 15 hr. All cells were harvested
41 to 43 hr posttransfection. CAT activities
were normalized to protein concentrations of
cell extracts. Shown are the averages and
standard deviations from three independent
experiments.
(B and C) HeLa (B) or L929 (C) cells were transfected with 3 mg of (PRDII)2CAT, 2 mg pCMV-lacZ, and 4 mg of pcDNA3-FlagMEKK1D (K432M)
or pcDNA3. Forty to 41 hr posttransfection, some cells were treated with 20 ng/ml mouse TNF-a (Boehringer) for 8 hr. All cells were harvested
48 to 49 hr posttransfection. CAT activities were normalized to those for b-galactosidase. Shown are the averages and standard deviations
from (B) one experiment performed in triplicate or (C) three independent experiments.
(D) L929 cells were transfected with 3 mg of (CRE)6CAT, 2 mg pCMV-lacZ, and 4 mg of pcDNA3-FlagMEKK1D (K432M) or pcDNA3. Forty to
41 hr posttransfection, some cells were treated with 1 mM 8-Br-cAMP for 8 hr. All cells were harvested 48 to 49 hr posttransfection. CAT
activities were normalized to those for b-galactosidase. Shown are the averages and standard deviations from three independent experiments.
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display MEKK1-inducible activity that is significantly di-
minished. Other experiments indicate that it is necessary
to transfect approximately 10-fold higher amounts of
wild-type IkBa plasmid in order to observe a comparably
reduced MEKK1-inducible reporter gene activity (data
not shown). These experiments therefore indicate that
site-specific phosphorylation of IkBa at Ser-32 and -36
plays a critical role in the MEKK1-dependent activation
of NF-kB.
MEKK1 Coordinately Activates the IkBa
Kinase and JNK In Vitro
The transfection data show that MEKK1 expression
leads to the site-specific phosphorylation of IkBa. To
investigate thepossibility that MEKK1 activates the IkBa
kinase, cytoplasmic extracts were prepared from unin-
duced HeLa cells by the rapid lysis procedure and then
treated with recombinant MEKK1D. In the absence of
MEKK1D, these extracts show no significant site-spe-
cific IkBa kinase or JNK activity when incubated with in
vitro-translated, 35S-labeled IkBa or c-Jun, respectively
Figure 3. MEKK1 Activation of NF-kB Is through Site-Specific Phos- (Figure 4A, lanes 2 and 6). By contrast, when recombi-
phorylation of IkBa
nant MEKK1D was added to the extract, site-specific
(A) HeLa cells were transfected with 0.3 mg of expression vectors for phosphorylation of c-Jun was observed (compare laneswild-type (WT) (pCMV4-FlagIkBa) or mutant (M) (pCMV4-FlagIkBa
7 and 9). Importantly, site-specific IkBa kinase activity[S32A/S36A]) IkBa, 3 mg of pCMV5-MEKK1 or pCMV5, and 3 mg
was also observed (compare lanes 3 and 5), butof SP72. Forty-one hr posttransfection, epitope-tagged IkBa was
immunoprecipitated, and somesamples weretreated with calf intes- MEKK1D alone fails to induce this site-specific phos-
tinal alkaline phosphatase (CIP). All samples were then subjected phorylation (lane 1). To rule out the possibility that
to 10% SDS-PAGE, transferred to nitrocellulose membrane, and MEKK1D inactivates an IkBa phosphatase, extracts
probed with anti-IkBa antibodies. were incubated with MEKK1D in the absence or pres-
(B) HeLa cells were transfected with 3 mg of (PRDII)2CAT, 10 ng of
ence of the phosphatase inhibitor okadaic acid (FigurepCMV4-FlagIkBa, pCMV4-FlagIkBa (S32A/S36A) or pCMV4, and 4
4B). In the absence of okadaic acid, the MEKK1D-mg of pCMV5-MEKK1 or pCMV5. Cells were harvested 38 to 43 hr
posttransfection. CAT activities were normalized to protein concen- induced IkBa shift is largely abolished (compare lanes
trations of cellextracts. Shown are theaverages andstandard devia- 2 and 3). Thus, the effects of MEKK1D cannot be ac-
tions from three independent experiments. counted for solely by the inactivation of an okadaic acid±
sensitive IkBa phosphatase, implying that MEKK1D acti-
vates the IkBa kinase. We conclude that MEKK1Dexpression vectors for Flag-tagged wild-type or mutant
coordinately activates the IkBa kinase and JNK path-(S32A/S36A) IkBa, and an expression vector for MEKK1
ways in cytoplasmic extracts.or the expression vector alone. IkBa was then immuno-
precipitated with anti-Flag antibodies, and then visual-
ized by Western blotting using anti-IkBa antibodies. MEKK1 Directly Activates the IkBa Kinase
In the JNK pathway, MEKK1 phosphorylates and acti-MEKK1 induces the appearance of an IkBa species with
reduced mobility compared to that isolated from unin- vates MKK4, which, in turn, activates JNK. It is therefore
possible that IkBa could be a substrate for MEKK1,duced cells (Figure 3A, lane 2). This species is sensitive
to treatment with calf intestinal alkaline phosphatase MKK4, or JNK. When expressed as recombinant pro-
teins, however, neither MKK4 nor JNK1 phosphorylated(compare lanes 2 and 6), consistent with its being a
phosphorylated form of IkBa. Most importantly, Ser-to- IkBa, with appropriate control experiments demonstra-
ting that these proteins were enzymatically active (dataAla mutations at residues 32 and 36 of IkBa abolish
this species (lane 4). Thus, MEKK1 induces site-specific not shown). MEKK1D did phosphorylate IkBa directly;
however, the degree of phosphorylation was over 10-phosphorylation of IkBa at Ser-32 and -36.
If the MEKK1-dependent phosphorylation of these fold less than that seen with MKK4 as a substrate, and,
as shown below, MEKK1D does not phosphorylate IkBaserine residues is functionally important, their substitu-
tion by alanines should make IkBa degradation and at Ser-32 or -36. In addition, recent experiments indicate
the IkBa kinase activity resides in a large, approximatelyhence NF-kB activation refractory to MEKK1 stimula-
tion. To test this possibility, HeLa cells were transfected 700 kDa, multiprotein complex (Chen et al., 1996), and
Western blotting of this complex fails to reveal the pres-with the PRDII reporter gene and expression vectors for
wild-type or mutant (S32A/S36A) IkBa or expression ence of MEKK1, MKK4, JNK1, or JNK2 (data not shown).
A reasonable hypothesis, therefore, is that MEKK1 orvector alone and either expression vector for MEKK1 or
expression vector alone. HeLa cells transfected with one of the downstream kinases phosphorylates IkBa
indirectly by stimulating the IkBa kinase.wild-type IkBa display MEKK1-inducible reporter gene
activity that isvirtually the same as that of control (Figure To distinguish between these possibilities, MEKK1D
was incubated with purified, ubiquitination-inducible3B). In contrast, HeLa cells transfected with mutant IkBa
MEKK1 Activates the IkBa Kinase Complex
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Figure 4. MEKK1 Directly Activates the IkBa
Kinase
(A) Uninduced HeLa cell cytoplasmic extracts
(2 mg) prepared by the rapid lysis procedure
were incubated with 35S-labeled wild-type
(WT) or mutant (S32A/S36A, M) IkBa, or wild-
type (WT) or mutant (S63A/S73A, M) c-Jun in
the absence or presence of 20 ng MEKK1D
for 1 hr at 308C in the presence of 2.5 mM
okadaic acid. An additional incubation (lane
1) contained 20 ng MEKK1D and 35S-labeled
IkBa in the absence of extract. Reaction
products were subjected to 10% SDS-PAGE
and analyzed by autoradiography. Molecular
weight markers (in kilodaltons) are indicated
to the left.
(B) Uninduced HeLa cell cytoplasmic extracts
(2 mg) prepared by the rapid lysis procedure
were incubated with 35S-labeled IkBa in the
absence or presence of 20 ng MEKK1D and/
or 2.5 mM okadaic acid for 1 hr at 308C. Reac-
tion products were subjected to 10% SDS-
PAGE and analyzed by autoradiography.
(C) Purified IkBa kinase was incubated with
wild-type (WT), mutant (S32A/S36A) (M),
or immunoprecipitated wild-type (IP) 35S-labeled FlagIkBa in the absence or presence of 20 ng wild-type (WT) or mutant (K432M) (M) MEKK1D,
or 0.9 mg GST-Ubc5 1 0.5 mg/ml ubiquitin for 1 hr at 308C in the presence of 2.5 mM okadaic acid. An additional incubation (lane 1) contained
20 ng MEKK1D and 35S-labeled FlagIkBa in the absence of IkBa kinase. Reaction products were subjected to 10% SDS-PAGE and analyzed
by autoradiography. In lane 8, additional bands at higher molecular weights than phosphorylated IkBa represent ubiquitinated IkBa species,
owing to the presence of ubiquitination components (Chen et al., 1995, 1996).
(D) Purified IkBa kinase in the absence or presence of 5, 10, or 20 ng MEKK1D was incubated with 35S-labeled FlagIkBa for 1 hr at 308C in
the presence of 2.5 mM okadaic acid. Reaction products were subjected to 10% SDS-PAGE and analyzed by autoradiography.
IkBa kinase (Chen et al., 1996) and in vitro±translated, The MEKK1-Inducible IkBa Kinase Is a High
Molecular Weight Complex35S-labeled IkBa (Figure 4C). In the absence of the ubi-
quitin-conjugating enzyme Ubc5 and ubiquitin, the IkBa To further examine the relationship between the
MEKK1D- and the ubiquitination-inducible IkBa kinasekinase is inactive (lane 3), while in their presence the
kinase is active, as evidenced by the shift in mobility of previously reported (Chen et al., 1996), we fractionated
HeLa cell cytoplasmic extracts and assayed for boththe 35S-labeled IkBa (lane 8), as shown previously (Chen
et al., 1996). Strikingly, addition of MEKK1D indepen- activities (Figure 5). Notably, both MEKK1D- and ubiqui-
tination-inducible IkBa kinase activities copurify duringdently activates the IkBa kinase (lane 4), while MEKK1D
alone does not site-specifically phosphorylate IkBa the first four steps of fractionation, which include ion
exchange chromatography, ammonium sulfate frac-(lane 2). That this shift reflects phosphorylation of IkBa
at Ser-32 and -36 is indicated by the fact that the S32A/ tionation, hydroxylapatite chromatography (data not
shown), and gel filtration (Figures 5A and 5B). With re-S36A mutant fails todisplay this shift (lane 5). The activa-
tion of the IkBa kinase depends on the catalytic activity gard to the gel filtration step, the peak of MEKK1D-
inducible IkBa kinase activity elutes at a position (frac-of MEKK1D, since mutant MEKK1D(K432M) fails to acti-
vate (lane 6). Neither recombinant MKK4 nor JNK1 aug- tions 19 to 20) corresponding to a native molecular
weight of approximately 700 kDa, indistinguishable fromments MEKK1D stimulation of the IkBa kinase (data not
shown), ruling out the possibility that MEKK1D activation that of the ubiquitination-inducible IkBa kinase (Chen
et al., 1996). Further fractionation by anion exchangeof the IkBa kinase is mediated by an insect (Sf9) cell
MKK4- or JNK-like activity copurifying in trace amounts chromatography reveals that the MEKK1D-inducible
IkBa kinase activity elutes in a broader peak than thewith the MEKK1D protein. To eliminate the possibility
that MEKK1D activation of the IkBa kinase is mediated ubiquitination-inducible activity (Figures 5C and 5D).
Thus, some fractions (e.g., 32 and 33) are inducible bythrough a factor present in the wheat germ extract em-
ployed for in vitro translation of IkBa, immunoprecipi- both MEKK1D and ubiquitination, while others (e.g., 29
and 30) are inducible only by MEKK1D. We concludetated IkBa was employed as a substrate. As shown in
lane 7, this IkBa is also a substrate for MEKK1D-acti- that the two kinase complexes are largely similar but
may have subtle differences in structure or subunit com-vated IkBa kinase. We conclude that MEKK1D activation
of the IkBa kinase is direct. Additional experiments indi- position.
cate that MEKK1D is a potentactivator of the IkBa kinase
(Figure 4D), with activation demonstrable with MEKK1D MEKK1 Is a Selective Activator of the IkBa Kinase
To examine the specificity of MEKK1D activation of thedoses as low as 5 ng (lane 2). Finally, IkBa complexed
with RelA (p65) is a substrate for MEKK1D-activated IkBa kinase, three additional kinases, casein kinase II
(CKII), protein kinase A (PKA), and protein kinase CzIkBa kinase, just as it is for the ubiquitination-activated
kinase (data not shown). (PKCz), were assayed for their capacity to activate the
Cell
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Figure 5. The MEKK1-Inducible IkBa Kinase
Is a High Molecular Weight Complex
HeLa cell cytoplasmic extracts were fraction-
ated as described in Experimental Proce-
dures and then chromatographed on (A and
B) a Superdex-200 gel filtration column fol-
lowed by a (C and D) Mono-Q ion exchange
column. Fractions were assayed for IkBa ki-
nase activity with 35S-labeled FlagIkBa in the
presence of either (A and C) ubiquitination
components or (B and D) 10 ng MEKK1D for
1 hr at 378C in the presence of 3 mM okadaic
acid. Reaction products were subjected to
9% SDS-PAGE and analyzed by autoradiog-
raphy. The numbers 670 and 440 in (A) and (B)
indicate elution positions of molecular weight
standards (in kilodaltons).
IkBa kinase (Figure 6). In marked contrast to MEKK1D, suggests that MEKK1D phosphorylates the IkBa kinase
complex. To further examine this possibility, MEKK1D-none of these enzymes activates the IkBa kinase (Figure
6A). The enzymatic activity of the kinases is demon- activated IkBa kinase was incubated with or without
calf intestinal alkaline phosphatase, and the IkBa kinasestrated by their roughly comparable degree of phos-
phorylation of recombinant IkBa with [g-32P]ATP (Figure was then assayed for activity against 35S-labeled IkBa
in the absence or presence of MEKK1D. As shown in6B). The experiment shown in Figure 6A also demon-
strates that none of the enzymes, aside from the IkBa Figure 7A, treatment of the MEKK1D-activated IkBa ki-
nase with phosphatase results in inactivation of IkBakinase, phosphorylates IkBa at Ser-32 or -36 under the
conditions employed. Phosphorylation by these other kinase activity (compare lanes 2 and 4). Subsequent
addition of MEKK1D results in substantial, though in-enzymes presumably occurs at residues other than Ser-
32 or -36. complete, restoration of IkBa kinase activity (compare
lanes 2, 3, and 4). To extend these observations, the
purified IkBa kinase was incubated with or withoutMEKK1 Activates the IkBa Kinase Complex
by Phosphorylation MEKK1D in the presence of [g-32P]ATP (Figure 7B). In
the absence of MEKK1D, 32P label was incorporated intoThe fact that the catalytically inactive MEKK1D does not
activate the IkBa kinase (Figure 4C, lane 6) strongly three subunits (approximately 200, 180, and 120 kDa)
of the IkBa kinase complex (lane 2). In the presence of
MEKK1D, 32P label was incorporated into three addi-
tional subunits of molecular weights of approximately
105, 64, and 54 kDa (lane 3). In conjunction with the
experimentemploying the catalytically inactive MEKK1D
(Figure 4C), these experiments show that MEKK1D acti-
vates the IkBa kinase complex by phosphorylation. We
are currently investigating which subunit(s) is the sub-
strate(s) for MEKK1.
Discussion
The activation of the IkBa kinase and JNK pathway by
a single protein, MEKK1, providesa compelling explana-
tion for how multiple stimuli can simultaneously activate
these two distinct kinases (Figure 8). Thus, TNF-a, UV
irradiation, and lipopolysaccharide have all been shown
Figure 6. MEKK1 Is a Selective Activator of the IkBa Kinase to activate the JNK pathway. Their implied activation of
MEKK1 now provides a mechanism for the activation(A) MEKK1D (10 ng), CKII (0.35 ng, 250 mU, New England Biolabs),
PKA (0.8 ng, 1 mU, New England Biolabs), and PKCz (15 ng, Pan- of the IkBa kinase. Stimuli such as phorbol myristate
Vera), either alone or in combination with purified IkBa kinase, were acetate/ionomycin could also potentially act through
incubated with 35S-labeled FlagIkBa for 30 min at 308C in the pres- this pathway; in T cells, for example, phorbol myristate
ence of 2.5 mM okadaic acid. An additional incubation (lane 2)
acetate and ionomycin synergistically activate the JNKcontained purified IkBa kinase and 35S-labeled FlagIkBa. Reaction
pathway (Su et al., 1994) and thus may activate the IkBaproducts were subjected to 10% SDS-PAGE and analyzed by
autoradiography. kinase through MEKK1. The coordinate activation of the
(B) Purified IkBa kinase, MEKK1D, CKII, PKA, and PKCz in the IkBa kinase and JNK raises the possibility that potential
amounts employed in (A) were incubated with 0.5 mg (His)6IkBa in upstream activators of MEKK1, such as the small GTP-
the presence of [g-32P]ATP. Reaction products were subjected to binding proteins Rac1, Cdc42, and Ras, as well as pro-
10% SDS-PAGE and analyzed by autoradiography. Relative kinase
tein kinases that they activate, such as PAK, may alsoactivities determined by phosphorimager analysis for the IkBa ki-
be common elements of a single upstream signal trans-nase, MEKK1D, CKII, PKA, and PKCz are 1, 0.6, 2.2, 1.0, and 1.3,
respectively. duction mechanism.
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Figure 8. Model Showing Coordinate Activation of the IkBa Kinase
and the JNK Pathway by MEKK1
Stressful stimuli such as TNF-a, UV irradiation, and lipopolysaccha-
ride (LPS) activate MEKK1 by as-yet-to-be-identified mechanisms
that involve small GTPases such as Rac1, Cdc42, and Ras and
Figure 7. MEKK1 Activates the IkBa Kinase Complex by Phosphor- possibly the protein kinase PAK. MEKK1, in turn, coordinately acti-
ylation vates the JNK pathwayÐwhich ultimately phosphorylates c-JunÐ
and the IkBa kinase. The IkBa kinase phosphorylates IkBa while(A) MEKK1D-activated IkBa kinase was incubated with or without
still bound to NF-kB, targeting IkBa for degradation by the ubiquitin-calf intestinal alkaline phosphatase (CIP, as indicated), and subse-
proteasome pathway and thereby liberating NF-kB. The IkBa kinasequently incubated with or without 12 ng MEKK1D (as indicated) and
can independently be activated by ubiquitination (Ub) enzymes (seewith 35S-labeled FlagIkBa for 60 min at 378C in the presence of 3
Chen et al., 1996).mM okadaic acid. Reaction products were subjected to 9% SDS-
PAGE and analyzed by autoradiography. The doublet above the
IkBa probably represents phosphorylation at one or both serines at
positions 32 and 36. in a GTP-dependent manner and thus its activity may
(B) MEKK1D and purified IkBa kinase, either alone or in combination, be regulated in a similar fashion (Russell et al., 1995).
were incubated in the presence of [g-32P]ATP. Reaction products
Indeed, Ha-Ras activation of NF-kB (Devary et al., 1993)were subjected to 8% SDS-PAGE and analyzed by autoradiography.
could be mediated, in part, by activation of MEKK1.Molecular weight markers (in kDa) are shown to the left. Dots indi-
cate bands (approximately 200, 180, and 120 kDa) present when the Aside from its interaction with Ras, little is known about
IkBa kinase is incubated with [g-32P]ATP in the absence of MEKK1D. the regulation and activation of MEKK1. The recent iden-
Bracket indicates bands present when MEKK1D is incubated with tification of MEKK1 as a large membrane-associated
[g-32P]ATP in the absence of the IkBa kinase, showing MEKK1D protein, with its C-terminal catalytic domain constituting
autophosphorylation.
less than 20% of the molecule, raises the possibility of
complex modes of regulation (Xu et al., 1996). While yet
Previous studies have implicated kinases other than
to be demonstrated, other MEKKs could conceivably
MEKK1 in the activation of NF-kB. For example, PKA
be regulated by otherupstream regulators such as Rac1,
has been shown to dissociate the NF-kB±IkB complex
Cdc42, and PAK. These data also leave open the possi-
(Ghosh and Baltimore, 1990), while PKCz coimmuno-
bility that there may be other IkBa kinases that respond
precipitates with a factor that can phosphorylate IkBa
to stimuli distinct from those that signal through MEKK1.
(Diaz-Meco et al., 1994); with regard to the latter, it has
We as well as others (Hirano et al., 1996) have shown
been suggested that PKCz activates a kinase that phos-
that dominant negative MEKK1 inhibits TNF-a activationphorylates IkBa. Neither PKA nor PKCz, however, phos-
of an NF-kB reporter gene in vivo. This is in contrast to aphorylates IkBa at Ser-32 and-36, nor does either acti-
recent report that reveals no effect of dominant negativevate the IkBa kinase (Figure 6A). Additional kinases that
MEKK1 in similar experiments, which conclude thathave been implicated in NF-kB activation are raf-1 and
MEKK1 lies on a pathway distinct from that of the IkBathe double-stranded RNA-activated protein kinase
kinase (Liu et al., 1996). At present, we have no explana-(PKR) (Finco and Baldwin, 1993; Yang et al., 1995). In
tion for this discrepancy. However, our transfection re-preliminary experiments, we have been unable to ob-
sults are strongly supported by the observation thatserve activation of the IkBa kinase by enzymatically
the IkBa kinase is phosphorylated and activated byactive c-raf (UBI) (data not shown). Additional studies
MEKK1D in vitro. We thus conclude that the IkBa kinasewill be required to determine the roles of raf and PKR
and MEKK1, or minimally an MEKK isoform, are indeedin NF-kB regulation.
part of the same pathway.MEKK1 is a member of a family of enzymes that share
The IkBa kinase can be activated by ubiquitinationa conserved C-terminal catalytic domain and may thus
independently of phosphorylation (Figure 8). To ourshare overlap in substrates (Lange-Carter et al., 1993;
knowledge, this dual regulation by phosphorylation orBlank et al., 1996; Xu et al., 1996). Hence, it is conceiv-
ubiquitination is unprecedented. Thus, the IkBa kinaseable that MEKK isoforms other than MEKK1 can activate
itself can be considered a signal integrator, respondingthe IkBa kinase. Different MEKK isoforms could poten-
to both phosphorylation and ubiquitination. Differenttially be involved insignaling responses to different stim-
uli. For example, MEKK1 has been shown to bind Ras stimuli may therefore activate one, the other, or both
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S36A) were gifts of Dr. Dean Ballard (Vanderbilt University) and havepathways. In principle, then, it may be possible to isolate
been described (Brockman et al., 1995). pcDNA1-cJun has beenan induced IkBa kinase species that is not ubiquitina-
described (Du et al., 1993). pcDNA1-cJun(S63A/S73A) was con-tion-dependent, or one that is not phosphorylation-
structed using overlapping polymerase chain reaction (Ausubel
dependent. Indeed, the fractionation of highly purified et al., 1989). pBS-IkBa, pBS-IkBa(S32A/S36A), pBS-FlagIkBa,
IkBa kinase by ion exchange chromatography reveals pBS-FlagIkBa(S32A/S36A), (PRDII)2CAT, (PRDIV)6CAT, (CRE)6CAT,
2110IFN-bCAT, and pCMV-lacZ have been described (MacGregorkinase species that are phosphorylation butnot ubiquiti-
and Caskey, 1989; Du and Maniatis, 1992; Thanos and Maniatis,nation inducible (Figures 5C and 5D).
1992; Chen et al., 1995).A puzzling result from previous studies is that while
IkBa kinase is easily assayed when present in HeLa
Tissue Culture and Transfection
cell S100 cytoplasmic extracts, the purified kinase is HeLa and L929 cells were maintained in DME media supplemented
inactive, requiring ubiquitination components for activity with 10% fetal bovine serum, 2 mM L-glutamine, 100 U/ml penicillin,
(Chen et al., 1996). One possibility is that purification and 100 mg/ml streptomycin. Transfections and virus infections,
performed in 3.5 cm diameter wells, were conducted as describedof the kinase separates the ubiquitination components
(Thanos and Maniatis, 1992). Cells were typically harvested at 41from the kinase; hence, the purified kinase is inactive.
to 49 hr posttransfection. CAT and b-galactosidase assays wereThe results described here raise a second and distinct
performed as described (Sambrook et al., 1989). Protein concentra-
possibility, namely that the IkBa kinase is activated by tions were measured by the Bradford method.
MEKK1 in the extract during the course of assay for
IkBa kinase activity. Thus, purification of the IkBa kinase Immunoprecipitations
Transfected IkBafrom S100 extracts removes it from both the ubiquitina-
Cell pellets obtained by harvesting 3.5 cm diameter wells were lysedtion components and MEKK1 present in the extract; in
by the addition of 200 ml of Buffer A (20 mM Tris, pH 7.5, 0.4 M KCl,fact, Western blotting indicates that MEKK1 is not pres-
4 mM b-glycerolphosphate, 0.1 mM sodium orthovanadate, 0.1%ent in the IkBa kinase complex (data not shown). Either
NP-40, 10% glycerol, 10 mg/ml leupeptin, 1 mM PMSF, and 1 mM
ubiquitination or MEKK1-dependent phosphorylation DTT), followed by three freeze/thaw cycles. After centrifugation at
can activate the purified IkBa kinase (Figure 4C). 14,000 3 g for 5 min at 48C, the supernatant (320 mg protein) was
incubated with 20 ml of M2-agarose (IBI-Kodak) in 1 ml of Buffer AThe detailed molecular mechanism by which MEKK1
with end-over-end rotation for 1 hr at 48C. Resins were then washedactivates the IkBa kinase remains to be determined.
three times with Buffer A and once with 0.1X Buffer A.One possibility is that MEKK1 inactivates a negative
35S-Labeled FlagIkBa
regulatory subunit of the IkBa kinase, just as cAMP In vitro±translated FlagIkBa was immunoprecipitated by incubation
binds to and induces the dissociation of the regulatory with 10 ml of M2-agarose in 1 ml of Buffer B (10 mM Tris, pH 7.6,
subunit of PKA (Francis and Corbin, 1994). Alternatively, 100 mM NaCl, 0.1% NP-40, 10 mg/ml leupeptin, 1 mM DTT) with
end-over-end rotation for 1 hr at 48C. Resins were then washedMEKK1 may activate the catalytic subunit of the IkBa
three times with Buffer B, once with Buffer C (10 mM Tris, pH 7.6,kinase that subsequently phosphorylates Ser-32 and
1 mg/ml BSA, 10 mg/ml leupeptin, 1 mM DTT), and then eluted by-36 of IkBa. Yet another possibility is that MEKK1 initi-
the addition of 24 ml of Buffer C containing 0.7 mg/ml Flag peptideates a MAPK-like cascade within the IkBa kinase com-
for 30 min on ice.
plex, with the terminal kinase the subunit that phos-
phorylates Ser-32 and -36; this would be somewhat Western Blotting
analogous to the organization of MAPK modules as high Proteins were electrophoresed by SDS-PAGE and transferred to
Immobilon-NC membranes (Millipore). The membranes weremolecular weight complexes in yeast (Choi et al., 1994).
blocked with 5% nonfat milk and probed with rabbit anti-IkBa poly-The incorporation of 32P into multiple subunits of the
clonal antibodies (C21, Santa Cruz Biotechnology). MembranesIkBa kinase complex in the presence of MEKK1D (Figure
were then incubated with goat anti-rabbit IgG-alkaline phosphatase
7) could be consistent with any of these possibilities. It or donkey anti-rabbit IgG-horseradish peroxidase conjugates, and
will be of interest to determine if the IkBa kinase sub- developed using standard chromogenic or Enhanced Chemilumi-
unit(s) targeted by MEKK1 is the same as those targeted nescence (Amersham) substrates, respectively. Western blots of
purified IkBa kinase employed antibodies (anti-MEKK1 [C22], anti-by the ubiquitination system. Further conclusions must
MKK4 [C20], anti-JNK1 [FL], anti-JNK2 [FL]) obtained from Santaawait the identification and characterization of subunits
Cruz Biotechnology.of the IkBa kinase.
Extract Preparation
HeLa S3 cell cytoplasmic extracts were prepared by two methods.Experimental Procedures
In the first (ªrapid lysis procedureº), mid±logarithmic growth phase
HeLa S3 cells cultured in RPMI 1640 media supplemented with 5%Plasmids
pCMV5-MEKK1 (which encodes the C-terminal 672 residues of horse serum, 2 mM L-glutamine, 100 U/ml penicillin, and 100 mg/
ml streptomycin were centrifuged at 2,600 3 g for 10 min. CellsMEKK1), pcDNA3-FlagMKK4, and pSRaHA-JNK1 were gifts of Dr.
Roger Davis (University of Massachusetts, Worcester) and have were resuspended in RPMI media containing 5% horse serum, and
then either mock treated or incubated with 1000 U/ml TNF-a atbeen described (Derijard et al., 1994, 1995; Whitmarsh et al., 1995).
pcDNA3-MEKK1 was constructed by subcloning the 2.4 kb EcoRI/ 378C. At various times, cells were centrifuged at 1,000 3 g for 1 min
at ambient temperature. Cells were then rapidly washed with ice-EcoNI (blunt) fragment of pCMV5-MEKK1 encoding MEKK1 into
the EcoRI/EcoRV site of pcDNA3. pcDNA3-FlagMEKK1D (K432M) cold PBS, centrifuged again at 1,000 3 g for 1 min, resuspended
in ice-cold 50 mM Tris (pH 7.5), 1 mM EGTA, and then immediatelyconsists of an N-terminal Flag epitope fused to the C-terminal 321
amino acid fragment of MEKK1 with the indicated mutation (amino lysed by dounce homogenization (15±20 strokes with an A-type
pestle). The crude lysate was clarified by centrifugation at 4,600 3acid numbering according to Lange-Carter et al., 1993) and was
constructed by polymerase chain reaction (Ausubel et al., 1989). g for 10 min at 48C, and the resulting supernatant immediately frozen
at 2808C. In the second method (ªS100º), HeLa S3 cells were swollenpcDNA3-FlagMEKK1D was constructed by replacing the 2.1 kb StuI
fragment of pcDNA3-FlagMEKK1D (K432M), which encodes the in a hypotonic buffer and lysed, followed by removal of nuclei and
centrifugation at 100,000 3 g as described (Dignam et al., 1983).C-terminal 262 amino acids with the corresponding fragment of
pcDNA3-MEKK1. pCMV4-FlagIkBa and pCMV4-FlagIkBa(S32A/ The supernatant was then dialyzed extensively against 20 mM Tris
MEKK1 Activates the IkBa Kinase Complex
221
(pH 7.5), 0.5 mM DTT. If not employed immediately, the extract was incubated with or without calf intestinal alkaline phosphatase (CIP)
in 50 mM Tris (pH 7.8), 0.1 mM EDTA for 30 min at 308C. IkBa kinasestored at 2808C.
was then separated from CIP and MEKK1D by chromatography on
a Superdex 200 column and assayed for IkBa kinase activity in thePurification of IkBa Kinase
absence or presence of MEKK1D.HeLa cell S100 cytoplasmic extract, prepared as above, was applied
to a Mono-Q anion exchange column. The IkBa kinase activity was
eluted with 0.2±0.3 M KCl in Buffer D (50 mM Tris, pH 7.5, 0.5 [g-32P]ATP Labeling of IkBa Kinase Complex
mM DTT), and then precipitated with 40% ammonium sulfate. The Two nanograms of MEKK1D was incubated in 7 ml of 70 mM Tris
resuspended precipitates were dialyzed against 10 mM K2HPO4- (pH 7.6), 7 mM MgCl2, 3.5 mM okadaic acid, and 140 mM ATP for
KH2PO4 (pH 7.0), 0.5 mM DTT, and then applied to a hydroxylapatite 15 min at 308C. Subsequently, purified IkBa kinase (from the second
column. After elution with 0.2 M K2HPO4-KH2PO4 (pH 7.0), the kinase- Mono Q chromatography step as described above) and 10 mCi of
containing fractions were applied to a Superdex-200 gel filtration [g-32P]ATP in a total volume of 3 ml were added and the incubation
column equilibrated with 50 mM Tris (pH 7.5), 0.5 mM DTT, and 150 continued at 308C for an additional 30 min. In control reactions,
mM NaCl. The high molecular weight fractions that contained the either MEKK1D or IkBa kinase was omitted.
kinase activity were applied to a Mono-Q column and eluted with
a linear gradient of 150±325 mM NaCl in Buffer D. Fractions from Acknowledgments
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